Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures

被引:22
|
作者
Runtz, Leonie [1 ]
Girard, Benoit [2 ]
Toussenot, Marion [1 ]
Espallergues, Julie [3 ]
De Maudave, Alexis Fayd'Herbe [1 ]
Milman, Alexandre [4 ]
deBock, Frederic [1 ]
Ghosh, Chaitali [5 ]
Guerineau, Nathalie C. [4 ]
Pascussi, Jean-Marc [6 ]
Bertaso, Federica [2 ]
Marchi, Nicola [1 ]
机构
[1] CNRS, Inst Funct Genom, Lab Cerebrovasc Mech Brain Disorders, UMR 5203,U1191,INSERM, Montpellier, France
[2] CNRS, Inst Funct Genom, Lab Pathophysiol Synapt Transmiss, UMR 5203,U1191,INSERM, Montpellier, France
[3] Histalim, Montpellier, France
[4] CNRS, Inst Funct Genom, Ion Channels Neuronal Excitabil & Dis, UMR 5203,U1191,INSERM, Montpellier, France
[5] Cleveland Clin, Cerebrovasc Res, Cleveland, OH 44106 USA
[6] CNRS, Lab Self Renewal & Differentiat Epithelia, Inst Funct Genom, UMR 5203,U1191,INSERM, Montpellier, France
关键词
inflammation; drug metabolism; epilepsy; liver; P450; BLOOD-BRAIN-BARRIER; XENOBIOTIC RECEPTORS; ABC TRANSPORTERS; MOUSE MODEL; EXPRESSION; NUCLEAR; INDUCTION; CORTISOL; STRESS; P450;
D O I
10.1111/epi.13942
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveAvailable evidence points to a role of cytochrome P450 (Cyp) drug biotransformation enzymes in central nervous system diseases, including epilepsy. Deviations in drug pharmacokinetic profiles may impact therapeutic outcomes. Here, we ask whether spontaneous recurrent seizure (SRS) activity is sufficient to modulate the expression of major Cyp enzymes in the liver and brain. MethodsUnilateral intrahippocampal (IH) kainic acid (KA) injections were used to elicit nonconvulsive status epilepticus (SE), epileptogenesis, and SRS, as monitored by video-electroencephalography. Intraperitoneal (IP) KA injection was used to trigger generalized tonic-clonic SE. KA-injected mice and sham controls were sacrificed at 24-72 hours and 1 week post-SE (IH or IP KA), and during the chronic stage (SRS; 6 weeks post-IH KA). Liver and brain tissues were processed for histology, real-time quantitative polymerase chain reaction, Western blot, or microsomal enzymatic assay. Cyp2e1, Cyp3a13, glial fibrillary acidic protein (GFAP), IBA1, xenobiotic nuclear receptors nr1i2 (PXR), nr1i3 (CAR) and nr3c1 (glucocorticoid receptor [GR]) expression was examined. Serum samples were obtained to assay corticosterone levels, a GR activator. ResultsA significant increase of Cyp3a13 and Cyp2e1 transcript level and protein expression was found in the liver and hippocampi during SRS, as compared to control mice. In the ipsilateral hippocampus, Cyp2e1 and Cyp3a protein upregulation during SRS positively correlated to GFAP expression. GFAP(+), and not IBA1(+), cells colocalized with Cyp2e1 or Cyp3a expression. In the liver, a trend increase in Cyp3a microsomal activity was found during SRS as compared to control mice. The transcript levels of the Cyp upstream regulators GR, xenobiotic nr1i2, and nr1i3 receptors were unchanged at SRS. Corticosterone levels, a GR ligand, were increased in the blood post-SE. SignificanceSRS modifies Cyp expression in the liver and the hippocampus. Nuclear receptors or inflammatory pathways are candidate mechanisms of Cyp regulation during seizures.
引用
收藏
页码:123 / 134
页数:12
相关论文
共 50 条
  • [31] Modulation of cytochrome P450 enzyme system by selected flavonoids
    Hodek, Petr
    Tepla, Martina
    Krizkova, Jitka
    Sulc, Miroslav
    Stiborova, Marie
    NEUROENDOCRINOLOGY LETTERS, 2009, 30 : 67 - 71
  • [32] Treprostinil Improves Hepatic Cytochrome P450 Activity during Rat Liver Transplantation
    Ghonem, Nisanne
    Yoshida, Junichi
    Murase, Noriko
    Strom, Stephen C.
    Venkataramanan, Raman
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (04) : 323 - 332
  • [33] Dissecting the function of cytochrome P450
    Boobis, AR
    Edwards, RJ
    Adams, DA
    Davies, DS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (01) : 81 - 89
  • [34] Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2
    Guo, Jingchao
    Zhu, Xiaohui
    Badawy, Sara
    Ihsan, Awais
    Liu, Zhenli
    Xie, Changqing
    Wang, Xu
    CURRENT DRUG METABOLISM, 2021, 22 (01) : 40 - 49
  • [35] Engineering of daidzein 3′-hydroxylase P450 enzyme into catalytically self-sufficient cytochrome P450
    Choi, Kwon-Young
    Jung, EunOk
    Jung, Da-Hye
    An, Byeo-Ri
    Pandey, Bishnu Prasad
    Yun, Hyungdon
    Sung, Changmin
    Park, Hyung-Yeon
    Kim, Byung-Gee
    MICROBIAL CELL FACTORIES, 2012, 11
  • [36] Novel dog hepatic cytochrome P450 3A293 oxidizes endogenous testosterone and estradiol
    Uno, Yasuhiro
    Ushirozako, Genki
    Murayama, Norie
    Yamazaki, Hiroshi
    BIOCHEMICAL PHARMACOLOGY, 2025, 235
  • [37] Pregnenolone 16a-carbonitrile negatively regulates hippocampal cytochrome P450 enzymes and ameliorates phenytoin-induced hippocampal neurotoxicity
    Zhang, Shuai
    Wang, Tingting
    Feng, Ye
    Li, Fei
    Qu, Aijuan
    Guan, Xiuchen
    Wang, Hui
    Xu, Dan
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2023, 13 (12) : 1510 - 1525
  • [38] Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation
    Grant, Marianne K. O.
    Abdelgawad, Ibrahim Y.
    Lewis, Christine A.
    Zordoky, Beshay N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [39] Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs
    Nishimuta, Haruka
    Nakagawa, Tetsuya
    Nomura, Naruaki
    Yabuki, Masashi
    XENOBIOTICA, 2013, 43 (11) : 948 - 955
  • [40] TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease
    Chaluvadi, Madhusudana R.
    Nyagode, Beatrice A.
    Kinloch, Ryan D.
    Morgan, Edward T.
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (03) : 464 - 471